# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed May 18, 2022

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2022-05-18
- Accepted by EDGAR: May 18, 2022, 16:01 ET
- Period: 2022-05-18
- Accession: 0001193125-22-154021
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000119312522154021/d272923d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000119312522154021/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000119312522154021/d272923d8k.htm

Filed May 18, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-154021. Last ingested by Listed: Nov 14, 2026, 23:22 ET. No prices; not investment advice.
